Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Focus on metabolic and nutritional correlates of polycystic ovary syndrome and update on nutritional management of these critical phenomena.

Rondanelli M, Perna S, Faliva M, Monteferrario F, Repaci E, Allieri F.

Arch Gynecol Obstet. 2014 Dec;290(6):1079-92. doi: 10.1007/s00404-014-3433-z. Epub 2014 Sep 9. Review.

PMID:
25200687
2.

Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines.

Moran LJ, Ko H, Misso M, Marsh K, Noakes M, Talbot M, Frearson M, Thondan M, Stepto N, Teede HJ.

J Acad Nutr Diet. 2013 Apr;113(4):520-45. doi: 10.1016/j.jand.2012.11.018. Epub 2013 Feb 16. Review.

PMID:
23420000
3.
4.

Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss.

Spanos N, Tziomalos K, Macut D, Koiou E, Kandaraki EA, Delkos D, Tsourdi E, Panidis D.

Obes Facts. 2012;5(4):495-504. doi: 10.1159/000341579. Epub 2012 Jul 23.

5.

Dietary intake, eating behaviors, and quality of life in women with polycystic ovary syndrome who are trying to conceive.

Turner-McGrievy G, Davidson CR, Billings DL.

Hum Fertil (Camb). 2015 Mar;18(1):16-21. doi: 10.3109/14647273.2014.922704. Epub 2014 Jun 12.

PMID:
24921163
6.

Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.

Toscani MK, Mario FM, Radavelli-Bagatini S, Spritzer PM.

Nutr Res. 2011 Feb;31(2):97-103. doi: 10.1016/j.nutres.2011.01.009.

7.

Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.

Graff SK, Mário FM, Alves BC, Spritzer PM.

Fertil Steril. 2013 Oct;100(4):1081-8. doi: 10.1016/j.fertnstert.2013.06.005. Epub 2013 Jul 2.

PMID:
23830153
8.

Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.

Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G.

Fertil Steril. 2008 Apr;89(4):899-906. Epub 2007 Nov 5.

PMID:
17980364
9.

Nutritional management in women with polycystic ovary syndrome: A review study.

Faghfoori Z, Fazelian S, Shadnoush M, Goodarzi R.

Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S429-S432. doi: 10.1016/j.dsx.2017.03.030. Epub 2017 Apr 5. Review.

PMID:
28416368
10.

Effect of a low-starch/low-dairy diet on fat oxidation in overweight and obese women with polycystic ovary syndrome.

Pohlmeier AM, Phy JL, Watkins P, Boylan M, Spallholz J, Harris KS, Cooper JA.

Appl Physiol Nutr Metab. 2014 Nov;39(11):1237-44. doi: 10.1139/apnm-2014-0073. Epub 2014 Aug 11.

11.

Diet, physical exercise and Orlistat administration increase serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS).

Vosnakis C, Georgopoulos NA, Rousso D, Mavromatidis G, Katsikis I, Roupas ND, Mamali I, Panidis D.

Gynecol Endocrinol. 2013 Mar;29(3):242-5. doi: 10.3109/09513590.2012.736557. Epub 2012 Nov 30.

PMID:
23194076
12.

Lifestyle changes in women with polycystic ovary syndrome.

Moran LJ, Hutchison SK, Norman RJ, Teede HJ.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD007506. doi: 10.1002/14651858.CD007506.pub3. Review.

PMID:
21735412
13.

Overweight in polycystic ovary syndrome. An update on evidence based advice on diet, exercise and metformin use for weight loss.

Ravn P, Haugen AG, Glintborg D.

Minerva Endocrinol. 2013 Mar;38(1):59-76. Review.

PMID:
23435443
14.

Diet and nutrition in polycystic ovary syndrome (PCOS): pointers for nutritional management.

Farshchi H, Rane A, Love A, Kennedy RL.

J Obstet Gynaecol. 2007 Nov;27(8):762-73. Review.

PMID:
18097891
15.

An isocaloric low glycemic index diet improves insulin sensitivity in women with polycystic ovary syndrome.

Barr S, Reeves S, Sharp K, Jeanes YM.

J Acad Nutr Diet. 2013 Nov;113(11):1523-31. doi: 10.1016/j.jand.2013.06.347. Epub 2013 Aug 30.

PMID:
23999280
16.

Lifestyle changes in women with polycystic ovary syndrome.

Moran LJ, Hutchison SK, Norman RJ, Teede HJ.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD007506. doi: 10.1002/14651858.CD007506.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(7):CD007506.

PMID:
21328294
17.

Dietary management of women with polycystic ovary syndrome in the United Kingdom: the role of dietitians.

Jeanes YM, Barr S, Smith K, Hart KH.

J Hum Nutr Diet. 2009 Dec;22(6):551-8. doi: 10.1111/j.1365-277X.2009.00988.x.

PMID:
19735349
18.

The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome.

Panidis D, Tziomalos K, Papadakis E, Chatzis P, Kandaraki EA, Tsourdi EA, Katsikis I.

Clin Endocrinol (Oxf). 2014 Mar;80(3):432-8. doi: 10.1111/cen.12305. Epub 2013 Aug 28.

PMID:
23909452
19.

Diet-Induced Weight Loss Reduces DNA Damage and Cardiometabolic Risk Factors in Overweight/Obese Women with Polycystic Ovary Syndrome.

Soares NP, Santos AC, Costa EC, Azevedo GD, Damasceno DC, Fayh AP, Lemos TM.

Ann Nutr Metab. 2016;68(3):220-7. doi: 10.1159/000444130. Epub 2016 Apr 14.

PMID:
27073909
20.

Effect of metformin compared with hypocaloric diet on serum C-reactive protein level and insulin resistance in obese and overweight women with polycystic ovary syndrome.

Esfahanian F, Zamani MM, Heshmat R, Moini nia F.

J Obstet Gynaecol Res. 2013 Apr;39(4):806-13. doi: 10.1111/j.1447-0756.2012.02051.x. Epub 2012 Dec 21.

PMID:
23279603

Supplemental Content

Support Center